|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Therapeutic interventions for heart failure with preserved ejection fraction:A summary of current evidence显示文摘Heart failure with preserved ejection fraction(HFPEF)is common and represents a major challenge in cardiovascular medicine.Most of the current treatment of HFPEF is based on morbidity benefits and symptom reduction.Various pharmacological interventions available for heart failure with reduced ejection fraction have not been supported by clinical studies for HFPEF.Addressing the specific aetiology and aggressive risk factor modification remain the mainstay in the treatment of HFPEF.We present a brief overview of the currently recommended therapeutic options with available evidence. | Muhammad Asrar ul Haq Chiew Wong Vivek Mutha Nagesh Anavekar Kwang Lim Peter Barlis David L Hare | 2014 | World Journal of Cardiology2014，6，2： | 7 |
| 2 | Shortness of breath in clinical practice: A case for left atrial function and exercise stress testing for a comprehensive diastolic heart failure workup显示文摘The symptom cluster of shortness of breath(SOB) contributes significantly to the outpatient workload of cardiology services. The workup of these patients includes blood chemistry and biomarkers, imaging and functional testing of the heart and lungs. A diagnosis of diastolic heart failure is inferred through the exclusion of systolic abnormalities, a normal pulmonary function test and normal hemoglobin, coupled with diastolic abnormalities on echocardiography. Differentiating confounders such as obesity or deconditioning in a patient with diastolic abnormalities is difficult. While the most recent guidelines provide more avenues for diagnosis, such as incorporating the left atrial size, little emphasis is given to understanding left atrial function, which contributes to at least 25% of diastolic left ventricular filling; additionally, exercise stress testing to elicit symptoms and test the dynamics of diastolic parameters, especially when access to the 'gold standard' invasive tests is lacking, presents clinical translational gaps. It is thus important in diastolic heart failure work up to understand left atrial mechanics and the role of exercise testing to build a comprehensive argument for the diagnosis of diastolic heart failure in a patient presenting with SOB. | Pupalan Iyngkaran Nagesh S Anavekar Christopher Neil Liza Thomas David L Hare | 2017 | World Journal of Methodology2017，7，4： | 5 |
| 3 | Cardiorenal Syndrome显示文摘 | Claudio Ronco Mikko Haapio Andrew A. House Nagesh Anavekar Rinaldo Bellomo | 2008 | Journal of the American College of Cardiology2008，，19： | 5 |
| 4 | Cardiorenal Syndrome显示文摘 | Claudio Ronco Mikko Haapio Andrew A. House Nagesh Anavekar Rinaldo Bellomo | 2008 | Journal of the American College of Cardiology2008，，19： | 3 |
| 5 | 心肌梗死患者接受缬沙坦、卡托普利或两者联合治疗时心室容积和功能的变化 | Solomon S. D. Skali H. Anavekar N. S. 张步升 | 2005 | 世界核心医学期刊文摘(心脏病学分册)2005，0，11： | 2 |
| 6 | Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction显示文摘 | Anavekar NS McMurray JJ Velazquez EJ | 2004 | N Engl J Med2004，351，13： | 1 |
| 7 | Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction显示文摘 | Anavekar NS McMurray JJ Velazquez EJ | 2004 | NEJM2004，351，13： | 1 |
| 8 | Facial Sweet's syndrome mimicking rosacea fulminans 显示文摘 | Anavekar NS Williams R Chong AH | 2007 | Australas J Dermatol2007，48，1： | 1 |
| 9 | Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction显示文摘 | ANAVEKAR NS MCMURRAY JJ VELAZQUEZ EJ | 2004 | N Engl J Med2004，351，13： | 1 |
| 10 | Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study) 显示文摘 | Anavekar NS Skali H Bourgoun M | 2008 | AmJ Cardiol2008，101，： | 1 |
| 11 | Changes in ventfieular size and function in patients treated with valsartan, captopfil, or both after myocardial infarction显示文摘 | Solomon SD Skali H Anavekar NS | 2005 | Circulation2005，14，25： | 1 |
| 12 | Changes in Ventricular Size and Function in Patients Treated With Val sartan, Captopril, or Both After Myocardial Infarction 显示文摘 | Solomon SD Skali H Anavekar NS | 2005 | Circulation2005，111，： | 1 |
| 13 | Cardiorenal Syndrome显示文摘 | Claudio Ronco Mikko Haapio Andrew A. House Nagesh Anavekar Rinaldo Bellomo | 2008 | Journal of the American College of Cardiology2008，，19： | 1 |
| 14 | ,Nordlander,Relation between renal dysfimction and cardiovascular outcomes after myocardial infarction显示文摘 | Anavekar N S Mcmurray J J Velazquez E J Solomon S D Kober L Rouleau J L White H D R Maggioni A Dickstein K et al N Engl J Med | | 0，，： | 1 |
| 15 | Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction显示文摘 | Anavekar NS McMurray JJ Velazquez EJ | 2004 | N Engl J Med2004，351，13： | 1 |
| 16 | Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction显示文摘 | Anavekar NS McMurray JJ Velazquez EJ | 2004 | N Engl J Med2004，351，13： | 1 |
| 17 | Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction显示文摘 | JOSE P SKALI H ANAVEKAR N | 2006 | J Am Soc Nephrol2006，17，10： | 1 |
| 18 | Achieving autologous breast reconstruction for breast cancer patients in the setting of post-mastectomy radiotherapy显示文摘 | ANAVEKAR N S ROZEN W M LE ROUX C M | | 0，，01： | 1 |
| 19 | Two-dimensional assessment of right ventriculzr function: an echocardiographic-MRl correlative study 显示文摘 | Anavekar NS Gerson D Skali H | 2007 | Echocardiography2007，24，5： | 1 |
| 20 | Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction显示文摘 | Anavekar NS Mcmurray JJ Velazquez EG | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员